Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a new treatment that applies chemotherapeutic drugs into the peritoneal cavity as an aerosol under pressure. It’s a safe and feasible approach that improves local bioavailability of chemotherapeutic drugs as compared with conventional intraperitoneal chemotherapy.
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. PIPAC is an innovative approach to peritoneal carcinomatosis (PC) that applies chemotherapic drugs into peritoneal cavity as an under pressure air-flow. It improves local bioavailability of cytostatic drugs as compared with conventional intraperitoneal chemotherapy.
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. Pseudomyxoma Peritonei (PMP) is a rare syndrome defined by clinical, biological and histological features. Different histological classifications of PMP are used; the one proposed by Ronnet divided PMP into adenomucinosis (DPAM) and mucinous carcinomatosis (PMCA), with distinct presumed prognostic implications.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.